Skip to main content

Table 1 Previous studies reporting adherence to HU treatment in SCA

From: Rationale and design of mDOT-HuA study: a randomized trial to assess the effect of mobile-directly observed therapy on adherence to hydroxyurea in adults with sickle cell anemia in Tanzania

Author, Year

Study design

Sample size and population

Adherence assessment method

% adherence

Thornburg et al., 2010 [12]

Single site, cross sectional

75 (3.5–17.8 years)

Visit adherence, Morisky score, provider report, Pharmacy-refill

82, 84, 77, 49 respectively

Thornburg et al., 2010 [13]

Multisite randomized controlled trial (Baby HUG)

153, 9 months–1.5 years

80 % of liquid medication taken by volume remaining at study visit

89

Ware et al., 2002 [10]

Multisite randomized controlled trial (HUG-KIDS)

53, 5–15 years

Pill count

94

Kinney et al., 1999 [9]

Multisite randomized controlled trial (HUG-KIDS)

84, 5–15 y ears

Pill count

74

Candrilli et al., (2011) [4]

Retrospective insurance claims

312, mean age 21 years

Medication possession ratio

35